2024-02-14 |
2024-02-12 |
PS
Planned sale
|
Dorling Janet
Non-Executive Director
|
6,000
-100.0%
31.97
191,849
USD
|
6,000
-100.0%
|
31.97
|
191,849
USD
|
|
2024-01-22 |
2024-01-19 |
PS
Planned sale
|
McWherter Charles
President of R&D
Officer
|
3,125
-17.2%
23.68
73,988
USD
|
3,125
-17.2%
|
23.68
|
73,988
USD
|
|
2024-01-22 |
2024-01-19 |
PS
Planned sale
|
McWherter Charles
President of R&D
Officer
|
8,334
-35.7%
23.68
197,316
USD
|
8,334
-35.7%
|
23.68
|
197,316
USD
|
|
2024-01-22 |
2024-01-19 |
PS
Planned sale
|
McWherter Charles
President of R&D
Officer
|
1,916
-11.3%
23.66
45,340
USD
|
1,916
-11.3%
|
23.66
|
45,340
USD
|
|
2024-01-22 |
2024-01-19 |
PS
Planned sale
|
McWherter Charles
President of R&D
Officer
|
2,778
-15.6%
23.66
65,739
USD
|
2,778
-15.6%
|
23.66
|
65,739
USD
|
|
2024-01-22 |
2024-01-19 |
PS
Planned sale
|
McWherter Charles
President of R&D
Officer
|
2,250
-13.0%
23.67
53,262
USD
|
2,250
-13.0%
|
23.67
|
53,262
USD
|
|
2024-01-16 |
2024-01-16 |
PS
Planned sale
|
Quinlan Paul T
General Counsel
Officer
|
5,000
-100.0%
23.58
117,898
USD
|
5,000
-100.0%
|
23.58
|
117,898
USD
|
|
2024-01-16 |
2024-01-16 |
PS
Planned sale
|
Menold Daniel
Vice President, Finance
Officer
|
10,000
-100.0%
23.58
235,806
USD
|
10,000
-100.0%
|
23.58
|
235,806
USD
|
|
2024-01-10 |
2024-01-10 |
PS
Planned sale
|
Dorling Janet
Non-Executive Director
|
6,000
-100.0%
23.86
143,144
USD
|
6,000
-100.0%
|
23.86
|
143,144
USD
|
|
2023-12-18 |
2023-12-18 |
PS
Planned sale
|
McWherter Charles
President of R&D
Officer
|
6,504
-30.2%
21.48
139,703
USD
|
6,504
-30.2%
|
21.48
|
139,703
USD
|
|
2023-12-18 |
2023-12-18 |
PS
Planned sale
|
McWherter Charles
President of R&D
Officer
|
4,828
-24.3%
21.49
103,738
USD
|
4,828
-24.3%
|
21.49
|
103,738
USD
|
|
2023-12-15 |
2023-12-15 |
PS
Planned sale
|
Menold Daniel
Vice President, Finance
Officer
|
11,497
-100.0%
21.99
252,799
USD
|
11,497
-100.0%
|
21.99
|
252,799
USD
|
|
2023-12-15 |
2023-12-15 |
PS
Planned sale
|
Menold Daniel
Vice President, Finance
Officer
|
10,000
-100.0%
21.98
219,847
USD
|
10,000
-100.0%
|
21.98
|
219,847
USD
|
|
2023-12-15 |
2023-12-15 |
PS
Planned sale
|
Quinlan Paul T
General Counsel
Officer
|
5,000
-100.0%
21.98
109,903
USD
|
5,000
-100.0%
|
21.98
|
109,903
USD
|
|
2023-12-11 |
2023-12-11 |
PS
Planned sale
|
Dorling Janet
Non-Executive Director
|
6,000
-100.0%
20.07
120,422
USD
|
6,000
-100.0%
|
20.07
|
120,422
USD
|
|
2023-12-11 |
2023-12-11 |
PS
Planned sale
|
Shah Sujal
Chief Executive Officer
Executive Director
|
890
-0.5%
20.81
18,521
USD
|
890
-0.5%
|
20.81
|
18,521
USD
|
|
2023-12-11 |
2023-12-11 |
PS
Planned sale
|
Shah Sujal
Chief Executive Officer
Executive Director
|
63,975
-27.2%
19.99
1,278,649
USD
|
63,975
-27.2%
|
19.99
|
1,278,649
USD
|
|
2023-11-17 |
2023-11-17 |
PS
Planned sale
|
McWherter Charles
President of R&D
Officer
|
11,342
-43.1%
18.28
207,293
USD
|
11,342
-43.1%
|
18.28
|
207,293
USD
|
|
2023-11-17 |
2023-11-15 |
PS
Planned sale
|
Quinlan Paul T
General Counsel
Officer
|
5,000
-100.0%
17.38
86,889
USD
|
5,000
-100.0%
|
17.38
|
86,889
USD
|
|
2023-11-17 |
2023-11-15 |
PS
Planned sale
|
Menold Daniel
Vice President, Finance
Officer
|
0
17.38
0
USD
|
0
|
17.38
|
0
USD
|
|
2023-11-14 |
2023-11-13 |
PS
Planned sale
|
Shah Sujal
Chief Executive Officer
Executive Director
|
20,855
-10.9%
15.89
331,350
USD
|
20,855
-10.9%
|
15.89
|
331,350
USD
|
|
2023-11-14 |
2023-11-13 |
PS
Planned sale
|
Shah Sujal
Chief Executive Officer
Executive Director
|
44,008
-20.4%
15.89
699,309
USD
|
44,008
-20.4%
|
15.89
|
699,309
USD
|
|
2023-11-14 |
2023-11-10 |
PS
Planned sale
|
Dorling Janet
Non-Executive Director
|
7,000
-100.0%
15.24
106,700
USD
|
7,000
-100.0%
|
15.24
|
106,700
USD
|
|
2023-10-18 |
2023-10-18 |
PS
Planned sale
|
McWherter Charles
President of R&D
Officer
|
21,743
-59.2%
14.07
305,941
USD
|
21,743
-59.2%
|
14.07
|
305,941
USD
|
|
2023-10-18 |
2023-10-16 |
PS
Planned sale
|
Menold Daniel
Vice President, Finance
Officer
|
0
13.76
0
USD
|
0
|
13.76
|
0
USD
|
|
2023-10-18 |
2023-10-16 |
PS
Planned sale
|
Quinlan Paul T
General Counsel
Officer
|
5,000
-100.0%
13.76
68,798
USD
|
5,000
-100.0%
|
13.76
|
68,798
USD
|
|
2023-10-10 |
2023-10-09 |
PS
Planned sale
|
Shah Sujal
Chief Executive Officer
Executive Director
|
64,861
-27.5%
14.20
921,286
USD
|
64,861
-27.5%
|
14.20
|
921,286
USD
|
|
2023-09-29 |
2023-09-29 |
PS
Planned sale
|
EMSTER KURT VON
Non-Executive Director
|
15,921
-15.0%
15.68
249,675
USD
|
15,921
-15.0%
|
15.68
|
249,675
USD
|
|
2023-09-19 |
2023-09-18 |
PS
Planned sale
|
McWherter Charles
President of R&D
Officer
|
21,746
-59.2%
16.22
352,733
USD
|
21,746
-59.2%
|
16.22
|
352,733
USD
|
|
2023-09-19 |
2023-09-15 |
PS
Planned sale
|
Menold Daniel
Vice President, Finance
Officer
|
0
16.87
0
USD
|
0
|
16.87
|
0
USD
|
|
2023-09-19 |
2023-09-15 |
PS
Planned sale
|
Menold Daniel
Vice President, Finance
Officer
|
0
16.87
0
USD
|
0
|
16.87
|
0
USD
|
|
2023-09-19 |
2023-09-15 |
PS
Planned sale
|
Quinlan Paul T
General Counsel
Officer
|
24,000
-100.0%
16.87
404,916
USD
|
24,000
-100.0%
|
16.87
|
404,916
USD
|
|
2023-09-19 |
2023-09-15 |
PS
Planned sale
|
Quinlan Paul T
General Counsel
Officer
|
24,000
-100.0%
16.87
404,897
USD
|
24,000
-100.0%
|
16.87
|
404,897
USD
|
|
2023-09-19 |
2023-09-15 |
PS
Planned sale
|
Quinlan Paul T
General Counsel
Officer
|
5,000
-100.0%
16.87
84,328
USD
|
5,000
-100.0%
|
16.87
|
84,328
USD
|
|
2023-08-18 |
2023-08-18 |
PS
Planned sale
|
McWherter Charles
President of R&D
Officer
|
21,746
-59.2%
11.47
249,359
USD
|
21,746
-59.2%
|
11.47
|
249,359
USD
|
|
2023-08-16 |
2023-08-15 |
PS
Planned sale
|
Quinlan Paul T
General Counsel
Officer
|
5,000
-100.0%
11.91
59,551
USD
|
5,000
-100.0%
|
11.91
|
59,551
USD
|
|
2023-08-16 |
2023-08-15 |
PS
Planned sale
|
Menold Daniel
Vice President, Finance
Officer
|
0
12.13
0
USD
|
0
|
12.13
|
0
USD
|
|
2023-08-16 |
2023-08-15 |
PS
Planned sale
|
Menold Daniel
Vice President, Finance
Officer
|
0
11.92
0
USD
|
0
|
11.92
|
0
USD
|
|
2023-08-11 |
2023-08-09 |
PS
Planned sale
|
Menold Daniel
Vice President, Finance
Officer
|
20,945
-100.0%
12.35
258,744
USD
|
20,945
-100.0%
|
12.35
|
258,744
USD
|
|
2023-07-19 |
2023-07-18 |
PS
Planned sale
|
McWherter Charles
President of R&D
Officer
|
21,749
-59.2%
11.43
248,519
USD
|
21,749
-59.2%
|
11.43
|
248,519
USD
|
|
2023-07-14 |
2023-07-14 |
PS
Planned sale
|
Quinlan Paul T
General Counsel
Officer
|
5,000
-100.0%
11.81
59,050
USD
|
5,000
-100.0%
|
11.81
|
59,050
USD
|
|
2023-06-21 |
2023-06-20 |
PS
Planned sale
|
McWherter Charles
President of R&D
Officer
|
21,749
-59.2%
8.16
177,383
USD
|
21,749
-59.2%
|
8.16
|
177,383
USD
|
|
2023-05-19 |
2023-05-18 |
PS
Planned sale
|
McWherter Charles
President of R&D
Officer
|
21,749
-59.2%
9.08
197,387
USD
|
21,749
-59.2%
|
9.08
|
197,387
USD
|
|
2023-05-17 |
2023-05-15 |
PS
Planned sale
|
Quinlan Paul T
General Counsel
Officer
|
5,000
-100.0%
10.37
51,831
USD
|
5,000
-100.0%
|
10.37
|
51,831
USD
|
|
2023-04-17 |
2023-04-17 |
S
Sale
|
KIM DENNIS D
Chief Medical Officer
Officer
|
112,219
-84.9%
9.54
1,070,536
USD
|
112,219
-84.9%
|
9.54
|
1,070,536
USD
|
|
2023-04-17 |
2023-04-13 |
S
Sale
|
KIM DENNIS D
Chief Medical Officer
Officer
|
7,781
-28.0%
8.98
69,880
USD
|
7,781
-28.0%
|
8.98
|
69,880
USD
|
|
2023-03-30 |
2023-03-28 |
S
Sale
|
KIM DENNIS D
Chief Medical Officer
Officer
|
100
-0.5%
8.99
899
USD
|
100
-0.5%
|
8.99
|
899
USD
|
|
2022-06-07 |
2022-06-06 |
B
Purchase
|
Shah Sujal
Chief Executive Officer
Executive Director
|
51,301
+42.8%
1.95
100,037
USD
|
51,301
+42.8%
|
1.95
|
100,037
USD
|
|
2022-01-20 |
2022-01-19 |
B
Purchase
|
KIM DENNIS D
Chief Medical Officer
Officer
|
20,000
+inf%
3.04
60,800
USD
|
20,000
+inf%
|
3.04
|
60,800
USD
|
|
2019-10-15 |
2019-10-10 |
B
Purchase
|
Shah Sujal
Chief Executive Officer
Executive Director
|
5,000
+4.3%
4.30
21,500
USD
|
5,000
+4.3%
|
4.30
|
21,500
USD
|
|
2019-09-24 |
2019-09-23 |
B
Purchase
|
Shah Sujal
Chief Executive Officer
Executive Director
|
3,100
+2.8%
5.55
17,205
USD
|
3,100
+2.8%
|
5.55
|
17,205
USD
|
|
2019-09-24 |
2019-09-20 |
B
Purchase
|
Shah Sujal
Chief Executive Officer
Executive Director
|
1,900
+1.7%
5.50
10,450
USD
|
1,900
+1.7%
|
5.50
|
10,450
USD
|
|
2019-02-08 |
2019-02-07 |
S
Sale
|
GOLDFISCHER CARL
Non-Executive Director
|
11,675
-100.0%
9.02
105,328
USD
|
11,675
-100.0%
|
9.02
|
105,328
USD
|
|
2018-12-21 |
2018-12-21 |
B
Purchase
|
Shah Sujal
Chief Executive Officer
Executive Director
|
10,000
+10.0%
6.54
65,399
USD
|
10,000
+10.0%
|
6.54
|
65,399
USD
|
|
2018-12-19 |
2018-12-18 |
S
Sale
|
EMSTER KURT VON
Non-Executive Director
|
53,492
-29.0%
7.43
397,365
USD
|
53,492
-29.0%
|
7.43
|
397,365
USD
|
|
2018-12-19 |
2018-12-17 |
S
Sale
|
EMSTER KURT VON
Non-Executive Director
|
88,889
-32.5%
8.17
726,223
USD
|
88,889
-32.5%
|
8.17
|
726,223
USD
|
|
2018-10-16 |
2018-10-15 |
B
Purchase
|
Shah Sujal
Chief Executive Officer
Executive Director
|
5,000
+5.3%
9.90
49,500
USD
|
5,000
+5.3%
|
9.90
|
49,500
USD
|
|
2018-08-31 |
2018-08-29 |
PS
Planned sale
|
Menold Daniel
Vice President, Finance
Officer
|
5,000
-100.0%
13.00
65,000
USD
|
5,000
-100.0%
|
13.00
|
65,000
USD
|
|
2018-07-30 |
2018-07-27 |
B
Purchase
|
Shah Sujal
Chief Executive Officer
Executive Director
|
5,000
+5.6%
10.90
54,500
USD
|
5,000
+5.6%
|
10.90
|
54,500
USD
|
|
2018-06-07 |
2018-06-05 |
S
Sale
|
EMSTER KURT VON
|
920
-4.8%
12.51
11,509
USD
|
920
-4.8%
|
12.51
|
11,509
USD
|
|
2018-05-15 |
2018-05-11 |
B
Purchase
|
Shah Sujal
Chief Executive Officer
Executive Director
|
5,000
+5.9%
10.65
53,250
USD
|
5,000
+5.9%
|
10.65
|
53,250
USD
|
|
2018-03-23 |
2018-03-22 |
S
Sale
|
GOLDFISCHER CARL
|
15,000
-100.0%
13.03
195,375
USD
|
15,000
-100.0%
|
13.03
|
195,375
USD
|
|
2018-03-07 |
2018-03-05 |
PS
Planned sale
|
EMSTER KURT VON
Non-Executive Director
|
13,353
-4.7%
15.51
207,105
USD
|
13,353
-4.7%
|
15.51
|
207,105
USD
|
|
2018-02-20 |
2018-02-15 |
PS
Planned sale
|
EMSTER KURT VON
Non-Executive Director
|
68,712
-19.3%
14.49
995,637
USD
|
68,712
-19.3%
|
14.49
|
995,637
USD
|
|
2018-02-15 |
2018-02-14 |
PS
Planned sale
|
EMSTER KURT VON
Non-Executive Director
|
162,979
-31.4%
16.69
2,720,120
USD
|
162,979
-31.4%
|
16.69
|
2,720,120
USD
|
|
2018-02-15 |
2018-02-13 |
PS
Planned sale
|
EMSTER KURT VON
Non-Executive Director
|
55,078
-9.6%
13.51
744,104
USD
|
55,078
-9.6%
|
13.51
|
744,104
USD
|
|
2018-02-09 |
2018-02-07 |
PS
Planned sale
|
EMSTER KURT VON
Non-Executive Director
|
40,763
-8.9%
12.35
503,423
USD
|
40,763
-8.9%
|
12.35
|
503,423
USD
|
|
2018-02-07 |
2018-02-05 |
PS
Planned sale
|
EMSTER KURT VON
Non-Executive Director
|
18,831
-3.9%
12.14
228,608
USD
|
18,831
-3.9%
|
12.14
|
228,608
USD
|
|
2018-02-05 |
2018-02-02 |
PS
Planned sale
|
EMSTER KURT VON
Non-Executive Director
|
2,000
-0.4%
12.11
24,220
USD
|
2,000
-0.4%
|
12.11
|
24,220
USD
|
|
2018-02-05 |
2018-02-01 |
PS
Planned sale
|
EMSTER KURT VON
Non-Executive Director
|
88,098
-15.5%
12.15
1,070,391
USD
|
88,098
-15.5%
|
12.15
|
1,070,391
USD
|
|
2018-02-01 |
2018-01-31 |
PS
Planned sale
|
EMSTER KURT VON
Non-Executive Director
|
12,300
-2.1%
12.23
150,429
USD
|
12,300
-2.1%
|
12.23
|
150,429
USD
|
|
2018-02-01 |
2018-01-30 |
PS
Planned sale
|
EMSTER KURT VON
Non-Executive Director
|
85,339
-12.8%
12.22
1,042,843
USD
|
85,339
-12.8%
|
12.22
|
1,042,843
USD
|
|
2018-01-26 |
2018-01-25 |
PS
Planned sale
|
EMSTER KURT VON
Non-Executive Director
|
39,438
-5.6%
12.18
480,355
USD
|
39,438
-5.6%
|
12.18
|
480,355
USD
|
|
2018-01-24 |
2018-01-22 |
PS
Planned sale
|
EMSTER KURT VON
Non-Executive Director
|
138,253
-16.4%
10.40
1,437,831
USD
|
138,253
-16.4%
|
10.40
|
1,437,831
USD
|
|
2018-01-22 |
2018-01-19 |
PS
Planned sale
|
EMSTER KURT VON
Non-Executive Director
|
130,584
-13.4%
10.25
1,338,486
USD
|
130,584
-13.4%
|
10.25
|
1,338,486
USD
|
|